NCT04005872View on ClinicalTrials.gov

Clinical and Radiographic Evaluation of Nano Silver Fluoride Versus Calcium Hydroxide in Indirect Pulp Treatment

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

November 5, 2022

Study Completion Date

November 30, 2022

Conditions
Deep Caries
Interventions
DRUG

Nano Silver Fluoride

Nano silver fluoride (NSF) is a new material consisting of nano silver particles, chitosan and sodium fluoride. It is a bacteriostatic and bactericidal compound.

DRUG

Calcium hydroxide

Calcium hydroxide is a gold standard for indirect pulp capping which induces hard tissue.

Trial Locations (1)

Unknown

Heba Mohamed Refaat Fouad Genena, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04005872 - Clinical and Radiographic Evaluation of Nano Silver Fluoride Versus Calcium Hydroxide in Indirect Pulp Treatment | Biotech Hunter | Biotech Hunter